Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Equity, beginning balance at Jun. 30, 2024 $ 9 $ 335,162   $ (313,847) $ 21,324
Equity, beginning balance (shares) at Jun. 30, 2024 8,624        
Common stock issued   4     4
Common stock issued (shares) 2        
Vesting of RSUs (shares) 12        
Share-based compensation   415     415
Net loss       (3,989) (3,989)
Equity, ending balance at Sep. 30, 2024 $ 9 335,581   (317,836) 17,754
Equity, ending balance (shares) at Sep. 30, 2024 8,638        
Equity, beginning balance at Jun. 30, 2025 $ 19 347,085   (332,224) 14,880
Equity, beginning balance (shares) at Jun. 30, 2025 19,349        
Common stock issued $ 1 218     219
Common stock issued (shares) 905        
Share-based compensation   323     323
Unrealized loss on available-for-sale debt securities     $ (15)   (15)
Issuance of pre-funded warrants   46,352     46,352
Net loss       (5,720) (5,720)
Equity, ending balance at Sep. 30, 2025 $ 20 $ 393,978 $ (15) $ (337,944) $ 56,039
Equity, ending balance (shares) at Sep. 30, 2025 20,254